Compare TZOO & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TZOO | ARAY |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 55.2M |
| IPO Year | 2003 | 2006 |
| Metric | TZOO | ARAY |
|---|---|---|
| Price | $9.32 | $0.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $17.50 | $3.50 |
| AVG Volume (30 Days) | 373.2K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.41 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.98 | N/A |
| Revenue Next Year | $9.52 | $4.58 |
| P/E Ratio | $23.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $0.33 |
| 52 Week High | $15.08 | $2.10 |
| Indicator | TZOO | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 68.29 | 48.64 |
| Support Level | $6.75 | $0.34 |
| Resistance Level | $10.54 | $0.48 |
| Average True Range (ATR) | 0.80 | 0.04 |
| MACD | 0.28 | 0.00 |
| Stochastic Oscillator | 55.77 | 56.68 |
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.